# aurie

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aurie

- Industry: Medical Devices & Equipment
- Headquarters: New York, US
- Website: www.livewithaurie.com/
- Total disclosed funding: $2.2M
- Latest round: Seed (Jun 11, 2020)
- Investors on record: 1

## About

Aurie is an innovative medical technology company based in New York, focusing on enhancing the catheterization experience through advanced design and hygiene solutions that prioritize user convenience.Founded in 2018 in New York, Aurie specializes in catheter solutions. The company successfully raised USD 2.2 mn in a Seed round on June 11, 2020, led by Rhythm Venture Capital, completing its total funding of USD 2.2 mn. No significant pivots or changes in business strategy have been recorded since inception.Aurie Catheters specializes in innovative catheter solutions aimed at transforming the experience of catheterization for users. The core offering, the Aurie Catheter, features a unique insertion sleeve and introducer tip designed to safeguard against contamination during use, enabling users to catheterize conveniently while on the move. The catheter is constructed with polished eyelets intended to minimize urethral trauma and optimize emptying efficiency, all made from high-quality, phthalate- and BPA-free materials. Additionally, the proprietary articulating support handle enhances stability and prevents slippage during insertion. To streamline the reuse process, the Aurie System includes a portable Personal Disinfector that autonomously cleans, disinfects, and lubricates the catheter in just 36 minutes, requiring minimal user involvement. Aurie Catheters targets a diverse clientele, including individuals with chronic urinary conditions, healthcare providers, and facilities. The company's products are primarily marketed in North America and Europe, catering to users who seek greater independence and convenience in catheter management.The revenue model for Aurie Catheters is structured around direct-to-consumer sales as well as B2B partnerships with healthcare providers. The company offers its flagship product, the Aurie Catheter, along with the associated Personal Disinfector as a bundled solution to both individual consumers and institutional clients. Transactions typically occur through direct sales channels, where customers purchase the catheter and disinfector system outright. The pricing strategy reflects the high-quality design and innovative technology of the products, ensuring accessibility for both personal and clinical usage. Revenue streams are further supported by ongoing engagement with customers through updates on research and community initiatives, fostering a loyal customer base comprised of advocates for improved catheterization practices.Aurie plans to introduce new products designed to enhance user experience and address a wider range of needs in catheter management. The company targets expansion into additional markets within Europe and aims to launch these initiatives by 2023. The recent funding of USD 2.2 mn will be utilized to support product development, marketing efforts, and entry into new geographic regions, strengthening Aurie's presence in the catheterization space.

## Funding rounds

- Seed, Jun 11, 2020, $2.2M — Rhythm VC

## Investors

- Rhythm VC (https://capitalatlas.ai/funds/rhythm-vc) — Seed